|
CLCN3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.42680000003725E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.30510000373852E-08 |
| Normal-vs-Stage2 |
1.009610E-01 |
| Normal-vs-Stage3 |
5.792300E-02 |
| Normal-vs-Stage4 |
3.771600E-01 |
| Stage1-vs-Stage2 |
1.786030E-01 |
| Stage1-vs-Stage3 |
2.174000E-01 |
| Stage1-vs-Stage4 |
2.896000E-01 |
| Stage2-vs-Stage3 |
8.649600E-01 |
| Stage2-vs-Stage4 |
9.546200E-01 |
| Stage3-vs-Stage4 |
8.566200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.78843999999456E-05 |
| Normal-vs-AfricanAmerican |
1.008910E-04 |
| Normal-vs-Asian |
6.393500E-04 |
| Caucasian-vs-AfricanAmerican |
5.166000E-01 |
| Caucasian-vs-Asian |
3.971000E-01 |
| AfricanAmerican-vs-Asian |
5.243200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.05040000031309E-08 |
| Normal-vs-Female |
3.350600E-01 |
| Male-vs-Female |
4.958700E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.215300E-03 |
| Normal-vs-Extreme_Weight |
2.4766000361609E-09 |
| Normal-vs-Obese |
2.203100E-03 |
| Normal-vs-Extreme_Obese |
6.367900E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.965620E-01 |
| Normal_Weight-vs-Obese |
6.748400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.957400E-01 |
| Extreme_Weight-vs-Obese |
1.745770E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.265400E-01 |
| Obese-vs-Extreme_Obese |
7.737200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.148210E-01 |
| Normal-vs-Age(41-60Yrs) |
6.393400E-04 |
| Normal-vs-Age(61-80Yrs) |
3.1509999998125E-07 |
| Normal-vs-Age(81-100Yrs) |
1.383810E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.683600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.602200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.934200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.971700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.618800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.342400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.28550003764394E-09 |
| Normal-VS-Type2 PRCC |
2.083500E-02 |
| Normal-VS-KIRP CIMP |
9.363200E-01 |
| Normal-VS-Unclassified PRCC |
2.045400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.897540E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.893430E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.616600E-03 |
| Type2 PRCC-VS-KIRP CIMP |
3.946800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.370800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.036000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.58150000000501E-05 |
| Normal-vs-N1 |
3.583600E-01 |
| Normal-vs-N2 |
6.176400E-01 |
| N0-vs-N1 |
9.462100E-02 |
| N0-vs-N2 |
2.828600E-01 |
| N1-vs-N2 |
3.026000E-01 |
|
|
